ClinicalTrials.gg
DrugBiological

Peginterferon alfa-2b clinical trials

Also written PegIntron, PEG-interferon alfa-2b, SCH 054031 and SCH 54031.

studies test it
139
open now
15
in phase 3
44
first study started
1997

How each study uses peginterferon alfa-2b is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the peginterferon alfa-2b studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Jan 2001 · PEGINTRON · BLA 103949 (FDA, Drugs@FDA)
European Union
24 May 2000 · PegIntron · EMEA/H/C/000280 (EMA; now withdrawn)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Peginterferon alfa-2b
25
PEG-Intron
16
Pegylated interferon alfa-2b
12
Peginterferon α-2b injection
6
Pegylated interferon alpha-2b
5

Brand

PegIntron
25
Sylatron
5

Development codes

SCH 054031
7
SCH 54031
6
MK-4031
3

Other names

PEG-interferon alfa-2b
14
Pegylated Interferon alpha 2b
2
PegIFN alfa-2b
2

In one entry with another drug

Given together, or one or the other

PEGETRON combination therapy
2
Combination of pegylated interferon alfa-2b and ribavirin
2

Studies by the year they started

135 studies that test it; most in 2006 (11)

Studies that test peginterferon alfa-2b, by start year
YearStudies
19972
19982
20005
20014
200210
20036
20045
200510
200611
200710
20088
20093
20117
201210
20139
201411
20152
20161
20171
20191
20202
20211
20222
20231
20245
20253
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
22
Phase 2
47
Phase 3
44
Phase 4
21
No phase
14

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 55 · Other 84

Merck Sharp & Dohme LLC (43) · M.D. Anderson Cancer Center (6) · National Institute of Allergy and Infectious Diseases (NIAID) (4) · Tanabe Pharma Corporation (3) · National Cancer Institute (NCI) (3) · Xiamen Amoytop Biotech Co., Ltd. (2) · The Wistar Institute (2) · H. Lee Moffitt Cancer Center and Research Institute (2)

Often tested with

Tested in the same studies.

Ribavirin (41) · Boceprevir (5) · Telaprevir (4) · Imatinib (3) · Pembrolizumab (3) · Nilotinib (2) · Rituximab (2) · Temozolomide (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 6

Studies that test peginterferon alfa-2b.

Studies

Open first, then newest update. How each study uses peginterferon alfa-2b is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 139

See all 139 studies that test peginterferon alfa-2b →

Given beside what is tested · 51 — peginterferon alfa-2b is usual care or a partner of the new treatment

Showing 20 of 51.

As the comparator · 11 — what is tested is compared with peginterferon alfa-2b

What changed recently

From the registry's own updates since Oct 18, 2026.

Newly registered1

Codes

What other systems call peginterferon alfa-2b · ClinicalTrials.gg INT004289

  • MeSH (NLM) C417083peginterferon alfa-2bConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) G8RGG88B68PEGINTERFERON ALFA-2BConfirmed FDA, NLM, Wikidata
  • RxNorm 253453Confirmed FDA, Wikidata
  • Wikidata Q7160789peginterferon alfa-2bConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C1845Peginterferon Alfa-2bOne source FDA
  • DrugBank DB00022One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.